Abbott Laboratories / Fundamentals
Income statement
- Net revenue
€37.14B - Cost of goods sold
€16.29B - Gross profit
€20.85B - SG&A expenses
€10.30B - R&D expenses
€2.51B - EBITDA
€9.27B - D&A
€2.04B - EBIT
€6.52B - Interest expenses
€395.45M - EBT
€6.80B - Tax expenses
-€5.24B - Net income
€12.04B
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€38.77M - Changes in working capital
-€7.46B - Operating cash flow
€7.79B - Capex
€1.53B - Other investing cash flow
-€1.09B - Net investing cash flow
-€2.16B - Total cash dividends paid
-€3.42B - Issuance of common stock
€0.00 - Debt repayment
-€504.01M - Other financing cash flow
-€826.23M - Net financing cash flow
-€5.68B - Foreign exchange effects
€24.12M - Net change in cash
-€31.02M - Cash at end of period
€5.99B - Free cash flow
€9.32B
Balance sheet
- Cash and cash equivalents
€5.99B - Cash and short-term investments
€6.27B - Total receivables
€8.82B - Inventory
€5.99B - Other current assets
€0.00 - Total current assets
€21.08B - Property, plant & equipment
€9.82B - Goodwill
€20.64B - Intangible assets
€5.10B - Long-term investments
€825.36M - Other non-current assets
€14.91B - Total non-current assets
€51.29B - Total assets
€72.37B - Accounts payable
€3.71B - Short-term debt
€436.81M - Other current liabilities
€7.10B - Total current liabilities
€11.58B - Long-term debt
€11.14B - Deferred tax liabilities
€0.00 - Other non-current liabilities
€5.86B - Total non-current liabilities
€17.00B - Total liabilities
€28.58B - Common stock
€21.78B - Retained earnings
€41.76B - Other equity
-€5.67B - Total equity
€43.79B - Total liabilities and shareholders' equity
€72.37B
Company information
- Market capitalization
€199.42B - Employees
114K - Enterprise Value
€242.08B
Company ratios
- Gross margin
-
56.1% Worse than peer group: 73.7% - EBITDA margin
-
25.0% Even with peer group: 29.4% - EBIT margin
-
17.5% Worse than peer group: 25.2% - EBT margin
-
18.3% Even with peer group: 21.5% - Net margin
-
32.4% Better than peer group: 17.1% - ROE
-
27.5% Even with peer group: 27.0% - ROA
-
16.6% Even with peer group: 11.7% - Asset turnover
-
51.3% Worse than peer group: 69.2% - FCF margin
-
16.8% Even with peer group: 18.5% - FCF yield
3.1% - Efficiency ratio
75.0% - Net sales per employee
-
€325.79K - Net income per employee
-
€105.65K